Research Portfolio

Funding Opportunities

Join our Mailing List
Join our mailing list to be notified of new funding opportunities.

Your Email

To receive information about funding opportunities, events, and program updates.



Peyton Jacob, Ph.D.

University of California, San Francisco # of Grants: 5

Grants

Clinical Pharmacology of Tobacco Alkaloids 1995 (Cycle 4) $393,855
General Biomedical Science Research Project Awards

Clinical pharmacology of tobacco alkaloids 1998 (Cycle 7) $439,882
Nicotine Dependence Research Project Awards

Clinical Pharmacology of Tobacco Alkaloids 1992 (Cycle 1) $538,143
Public Health, Public Policy, and Economics Research Project Awards

Clinical pharmacology of tobacco alkaloids 2001 (Cycle 10) $373,408
General Biomedical Science Research Project Awards

Clinical Pharmacology of Tobacco Alkaloids 2006 (Cycle 15) $508,848
General Biomedical Science Research Project Awards
Publications

Gas chromatographic-mass-spectrometric method for determination of anabasine, anatabine, and other tobacco alkaloids in urine of smokers and smokeless tobacco users
Periodical: Index Medicus:
Authors: Jacob P III, Yu L, Liang G, Shulgin AT, Benowitz NL ART
Yr: 1993 Vol: 619 Nbr: 1 Abs: Pg: 49-61

Minor tobacco alkaloids as biomarkers for tobacco use; comparison of cigarette, smokeless tobacco, cigar, and pipe users
Periodical: American Journal of Public Health Index Medicus:
Authors: Jacob P III, Yu L, Shulgin AT, Benowitz NL ART
Yr: 1998 Vol: Nbr: Abs: Pg:

Minor tobacco alkaloids as biomarkers for tobacco use: comparison of cigarettes, smokeless tobacco, cigar and pipe users
Periodical: American Journal of Public Health Index Medicus:
Authors: Jacob P III, Shulgin AT, Yu L, Benowitz NL ART
Yr: 1999 Vol: 89 Nbr: Abs: Pg: 731-736

Anabasine and anatabine levels in urine: Biomarkers for tobacco use during nicotine replacement therapy.
Periodical: Cancer Epidemiology Biomarkers and Prevention Index Medicus:
Authors: Jacob P, Hatsukami DK, Severson H, Hall S, Yu L, and Benowitz NL ART
Yr: 2005 Vol: 14(6):1376 Nbr: Abs: Pg:

Anabasine and anatabine levels in urine: biomarkers for tobacco use during nicotine replacement therapy.
Periodical: Cancer Epidemiology Biomarkers and Prevention Index Medicus:
Authors: Jacob P, Hatsukami DK, Severson H, Hall S,Yu L, Benowitz NL ART
Yr: 2002 Vol: 11 Nbr: Abs: Pg: 1668-1673

Carcinogen Exposure During Short-Term Switching From Regular to Light cigarettes. Cancer Epidemioly, Biomarkers and Prevention, in press.
Periodical: Cancer, Epidemiology, Biomarkers and Prevention Index Medicus:
Authors: Neal L. Benowitz, Peyton, Jocob III ART
Yr: 2005 Vol: 14(6):1376 Nbr: Abs: Pg:

Occupational Physical activity and risk of adenocarcinoma of the esophagus and stomach
Periodical: International Journal of Cancer Index Medicus:
Authors: Vigen C, Bernstein L, Wu AH ART
Yr: 2006 Vol: 118 Nbr: Abs: Pg: 1004-1009

Sub-Picogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(-3-pyridy1)-1-butanol (NNAL) in human urine using liquid chromatography-tandem mass spectrometry.
Periodical: Analytical Chemistry Index Medicus:
Authors: Jacob P,III, Havel C, Lee D, Yu L, Eisner M, Benowitz N ART
Yr: 2008 Vol: Nbr: 80 Abs: Pg: 8115-8121